Copyright
©The Author(s) 2020.
World J Transplant. Nov 28, 2020; 10(11): 365-371
Published online Nov 28, 2020. doi: 10.5500/wjt.v10.i11.365
Published online Nov 28, 2020. doi: 10.5500/wjt.v10.i11.365
Admission | PA-day 2 | PA-day 4 | PA-day 6 | PA-day 8 | PA-day 10 | Clinic | |
Urea (mg/dL) | 45 | 49 | 53 | 59 | 50 | 42 | 40 |
Creatinine (mg/dL) | 1.1 | 1.2 | 1.3 | 1.4 | 1.2 | 1.1 | 0.9 |
eGFR (CKD-EPI) (mL/min/1.73 m²) | 58.5 | 52.7 | 47.8 | 43.7 | 52.7 | 58.5 | 76.4 |
Tacrolimus level (ng/mL) | 5.5 | 7 | - | 23.58 | 12 | 6.3 | 5.9 |
- Citation: Oguz EG, Atilgan KG, Cimen SG, Sahin H, Selen T, Ebinc FA, Cimen S, Ayli MD. COVID-19 infection in a kidney transplant recipient—special emphasis on pharmacokinetic interactions: A case report. World J Transplant 2020; 10(11): 365-371
- URL: https://www.wjgnet.com/2220-3230/full/v10/i11/365.htm
- DOI: https://dx.doi.org/10.5500/wjt.v10.i11.365